Viemed Healthcare, Inc. announced a recently completed non-invasive ventilation study led by Dr. William Frazier, Viemed's Chief Medical Officer. The study, entitled "Non-invasive Ventilation at Home Improves Survival and Decreases Healthcare Utilization in Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease with Chronic Respiratory Failure", has been published online and in print by the peer reviewed journal, Respiratory Medicine. This first of its kind investigation was performed in conjunction with Precision Health Economics, a leading bio-statistical and analytics firm. The study evaluated clinical outcomes in COPD patients with chronic respiratory failure (COPD-CRF) treated with non-invasive ventilation at home (NIVH) compared to similar patients with COPD-CRF who did not receive NIVH. The treatment and control groups were closely matched on a multitude of clinical and demographic variables and were statistically identical. The highlights of the results, all of which were highly statistically significant, are as follows: The group treated with NIVH had a 50% decrease in all-cause mortality during the study period . The group treated with NIVH had a 28% decline in the risk of hospitalization. The group treated with NIVH had a 52% reduction in the risk of an emergency room visit. All data for the study was obtained from the Medicare Limited Data Set and included patients who were diagnosed with COPD and CRF between 2012 and 2018.